GSK and SK will release competing products of the shingles vaccine ‘Zostavax’
It is expected that competing products of the only herpes zoster vaccine ‘Zostavax’ will be launched.
According to the industry concerned on the 15th, a multinational company ‘GSK’ and a domestic company ‘SK Chemicals’ are working on commercialization of each herpes zoster vaccine developing.
G...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
